Subgroup meta-analyses used to investigate heterogeneous outcomes showed similar risk estimates as overall, for cohort studies, studies using LUR models for NO2 exposure assessment, for postmenopausal women, and in strata of ER/PR status of the breast tumor. Here, ESR1 is linked to breast neoplasm.